SCHEMBL19254865

SCHEMBL19254865

C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cc(P(C)C)ccc34)n2)c(OC(F)F)cc1N(C)CCN(C)C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.72
MLNR O43193 1/20 0.70
KDM1A O60341 1/20 0.70
ABCB11 O95342 1/20 0.70
ERBB2 P04626 1/20 0.70
INSR P06213 1/20 0.70
CHRM2 P08172 1/20 0.70
HTR1A P08908 1/20 0.70
ADORA3 P0DMS8 1/20 0.70
DRD2 P14416 1/20 0.70
NQO2 P16083 1/20 0.70
ADRA2C P18825 1/20 0.70
DRD1 P21728 1/20 0.70
ERBB3 P21860 1/20 0.70
SLC6A2 P23975 1/20 0.70
HTR2A P28223 1/20 0.70
HTR2C P28335 1/20 0.70
ADORA2A P29274 1/20 0.70
SLC6A4 P31645 1/20 0.70
CCKAR P32238 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19254502 0.92 EGFR (0.72) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL17683107 0.91 EGFR (0.76) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL17553467 0.91 EGFR (0.85) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL23729070 0.91 EGFR (0.69) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL17683126 0.90 EGFR (0.71) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL17683340 0.90 EGFR (0.86) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL19210239 0.89 EGFR (0.71) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL17683120 0.89 EGFR (0.69) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL18607054 0.87 EGFR (0.85) EGFRMLNRKDM1AABCB11ERBB2
SCHEMBL23728971 0.86 EGFR (0.51) EGFRMLNRKDM1AABCB11ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3205650-B1 EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) 2021-08-04 EP disclosed
EP-3205650-A1 EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2017-08-16 EP disclosed